-
1
-
-
85006269354
-
Essential medicines for universal health coverage
-
published online Nov 7.
-
1 Wirtz, VJ, Hogerzeil, HV, Gray, AL, et al. Essential medicines for universal health coverage. Lancet, 2016 published online Nov 7. http://dx.doi.org/10.1016/S0140-6736(16)31599-9.
-
(2016)
Lancet
-
-
Wirtz, V.J.1
Hogerzeil, H.V.2
Gray, A.L.3
-
2
-
-
84971623153
-
Prices, costs, and affordability of new medicines for hepatitis C in 30 countries: an economic analysis
-
2 Iyengar, S, Tay-Teo, K, Vogler, S, et al. Prices, costs, and affordability of new medicines for hepatitis C in 30 countries: an economic analysis. PLoS Med, 13, 2016, e1002032.
-
(2016)
PLoS Med
, vol.13
, pp. e1002032
-
-
Iyengar, S.1
Tay-Teo, K.2
Vogler, S.3
-
3
-
-
84979518740
-
Estimating benzathine penicillin need for the treatment of pregnant women diagnosed with syphilis during antenatal care in high-morbidity countries
-
3 Taylor, MM, Nurse-Findlay, S, Zhang, X, et al. Estimating benzathine penicillin need for the treatment of pregnant women diagnosed with syphilis during antenatal care in high-morbidity countries. PLoS One, 11, 2016, e0159483.
-
(2016)
PLoS One
, vol.11
, pp. e0159483
-
-
Taylor, M.M.1
Nurse-Findlay, S.2
Zhang, X.3
-
4
-
-
84994016173
-
Chemotherapy drug shortages in paediatric oncology: a 14-year single-centre experience in Belgium
-
published online Oct 6.
-
4 Bauters, T, Claus, BO, Norga, K, et al. Chemotherapy drug shortages in paediatric oncology: a 14-year single-centre experience in Belgium. J Oncol Pharm Pract, 2015, 10.1177/1078155215610915 published online Oct 6.
-
(2015)
J Oncol Pharm Pract
-
-
Bauters, T.1
Claus, B.O.2
Norga, K.3
-
6
-
-
85005997777
-
The United Nations Secretary-General's High-Level Panel on Access to Medicines Report: promoting innovation and access to health technologies
-
(accessed Sept 26, 2016).
-
6 UN Secretary-General and Co-Chairs of the High-Level Panel. The United Nations Secretary-General's High-Level Panel on Access to Medicines Report: promoting innovation and access to health technologies. http://www.unsgaccessmeds.org/final-report/, 2016 (accessed Sept 26, 2016).
-
(2016)
-
-
-
7
-
-
84894259985
-
Paying twice: questions over high cost of cystic fibrosis drug developed with charitable funding
-
7 Cohen, D, Raftery, J, Paying twice: questions over high cost of cystic fibrosis drug developed with charitable funding. BMJ, 348, 2014, g1445.
-
(2014)
BMJ
, vol.348
, pp. g1445
-
-
Cohen, D.1
Raftery, J.2
-
8
-
-
85010742691
-
Full list of WHO medical product alerts
-
(accessed Oct 17, 2016).
-
8 WHO. Full list of WHO medical product alerts. http://www.who.int/medicines/publications/drugalerts/en/, 2016 (accessed Oct 17, 2016).
-
(2016)
-
-
-
9
-
-
85010819487
-
Future scenarios about drug development and drug pricing
-
2016. (accessed Sept 20, 2016).
-
9 Vandenbroeck, P, Raeymakers, P, Wickert, R, et al. Future scenarios about drug development and drug pricing. https://kce.fgov.be/sites/default/files/page_documents/KCE_271_Drug__Pricing_Report.pdf, 2016 2016. (accessed Sept 20, 2016).
-
(2016)
-
-
Vandenbroeck, P.1
Raeymakers, P.2
Wickert, R.3
|